Jinhua®Transfer Factor Oral Solution

Brand Name‌: Jinhua
Generic Name‌: Transfer Factor Oral Solution
R&D and Manufacturing Enterprise‌: Jinhua Enterprise (Group) Co., Ltd. Xi’an Jinhua Pharmaceutical Factory
Approval & Launch Time‌: Officially approved for marketing with the NMPA approval number H20013288
Storage Requirements‌: Sealed, stored in a cool and dark place, protected from high temperature and moisture
Specification‌: 10ml per vial, the common commercial package is 10ml × 6/8 vials per box

Category:

Description‌
Jinhua Brand Transfer Factor Oral Solution is a prescription chemical drug with the NMPA approval number ‌Guoyao Zhunzi H20013288‌. It is a clear, colorless to slightly yellow liquid, refined from the spleen of healthy pigs or cattle, containing polypeptide, ribose and other active immune-regulating components.

Indications‌
It is used for adjuvant treatment of viral or mycotic intracellular infections that are difficult to control with antibiotics, such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc. It can also be used as an adjuvant therapy for malignant tumors, and applicable to immune deficiency diseases including eczema, thrombocytopenia, repeated infection syndrome.

Dosage and Administration‌
Administration‌: Oral administration, take it directly, do not mix with overheated drinks or food.
Dosage‌: 10~20ml each time, 2 to 3 times a day, the specific course of treatment can be adjusted according to the doctor’s advice.

Precautions‌
Do not take it together with hot drinks or hot food, to avoid high temperature destroying the active ingredients and reducing the curative effect. Stop using it immediately if the liquid becomes turbid or discolored.

Contraindications‌
People who are allergic to any component of this product are strictly prohibited from using it.

Adverse Reactions‌
No clear related adverse reactions have been reported in clinical application so far, and no serious drug-related adverse events have been recorded.

Drug Interactions‌
No clinically confirmed adverse drug interactions have been found at present. If you are taking other drugs at the same time, please consult a physician or pharmacist before use.

Special Populations‌
Children: The dosage should be determined under the guidance of a physician or pharmacist, and must be used under adult supervision.
Pregnant and lactating women: Use with caution, and must follow professional medical advice before taking.
Elderly patients: Can take it according to the conventional recommended dosage, no special dose adjustment is required under normal liver and kidney function.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.